Pertussis toxin and use in vaccines
Cloning and sequencing of the Eco RI fragment of B. pertussis chromosomal DNA with 4696 base pairs, containing the genes which code for the five subunits of the pertussis toxin.A hybrid plasmid containing the DNA fragment or its further fragments and a micro-organism transformed by the hybrid plasmid and capable of expressing the cloned DNA fragment or further fragments thereof by synthesis of the pertussis toxin or one or more subunits of the pertussis toxin.The pertussis toxin or one or more subunits of the pertussis toxin so obtained are useful for the preparation of vaccines and diagnostic kits.
Latest Chiron S.p.A. Patents:
Claims
1. Pertussis toxin obtained by chemical synthesis or from microorganisms transformed with molecules of recombinant DNA containing the five genes that code for pertussis toxin, in which the subunits S1, S2, S3 and S4 are characterized by the aminoterminal sequences set forth in FIG. 2.
2. A method for the preparation of anti-pertussis vaccines comprising adding to said vaccines the pertussis toxin produced by chemical synthesis or from microorganisms transformed with molecules of recombinant DNA containing the five genes that code for pertussis toxin.
- Tamura, M, et. al. (1982) Biochemistry 21, 5516-6622. Sekura, R. D., et. al. (1983) J. Biol. Chem. 258, 14647-14651.
Type: Grant
Filed: Jun 6, 1995
Date of Patent: Jul 28, 1998
Assignee: Chiron S.p.A.
Inventors: Rino Rappuoli (Quercegrossa-Monteriggioni), Alfredo Nicosia (Siena), Maria Beatrice Arico (Quercegrossa)
Primary Examiner: Charles L. Patterson, Jr.
Attorneys: Woodcock, Washburn, Kurtz, Mackiewicz, et al., Woodcock, Washburn, Kurtz, Mackiewicz, et al.
Application Number: 8/467,154
International Classification: A61K 3910;